Correlation Between GlaxoSmithKline PLC and Value Equity
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Value Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Value Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Value Equity Institutional, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Value Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Value Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Value Equity.
Diversification Opportunities for GlaxoSmithKline PLC and Value Equity
-0.9 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Value is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Value Equity Institutional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Value Equity Institu and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Value Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Value Equity Institu has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Value Equity go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Value Equity
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Value Equity. In addition to that, GlaxoSmithKline PLC is 1.68 times more volatile than Value Equity Institutional. It trades about -0.23 of its total potential returns per unit of risk. Value Equity Institutional is currently generating about 0.33 per unit of volatility. If you would invest 2,069 in Value Equity Institutional on September 1, 2024 and sell it today you would earn a total of 116.00 from holding Value Equity Institutional or generate 5.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 95.45% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Value Equity Institutional
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Value Equity Institu |
GlaxoSmithKline PLC and Value Equity Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Value Equity
The main advantage of trading using opposite GlaxoSmithKline PLC and Value Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Value Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Value Equity will offset losses from the drop in Value Equity's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Value Equity vs. Black Oak Emerging | Value Equity vs. Barings Emerging Markets | Value Equity vs. Dws Emerging Markets | Value Equity vs. Ashmore Emerging Markets |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |